Cancer is a group of diseases marked by uncontrolled cell growth that can invade nearby tissues and spread (metastasize) to other parts of the body. It arises when genetic mutations disrupt normal cell‑cycle regulation, allowing cells to divide without the usual checks. Early detection and treatment improve survival rates for many cancer types.
Most cancers result from a combination of genetic predisposition and environmental exposures. Tobacco smoke, responsible for about 22% of global cancer deaths, introduces carcinogens that damage DNA. Excessive ultraviolet (UV) radiation, certain infections (e.g., human papillomavirus), and occupational chemicals also increase risk. Inherited mutations such as BRCA1/2 raise the likelihood of breast and ovarian cancers.
Diagnosis typically follows a stepwise approach:
Pathologists use the TNM staging system (Tumor size, Node involvement, Metastasis) to assign a stage from I to IV, guiding treatment decisions.
The following table shows the five cancers with the highest incidence in 2023 and their average five‑year survival rates.
| Cancer type | Estimated new cases (2023) | 5‑year survival (global avg.) |
|---|---|---|
| Breast | 2.3 million | ≈ 80 % |
| Lung | 2.2 million | ≈ 15 % |
| Colorectal | 1.9 million | ≈ 65 % |
| Prostate | 1.4 million | ≈ 95 % |
| Skin (non‑melanoma) | 1.2 million | ≈ 99 % |
These figures come from the International Agency for Research on Cancer (IARC) Global Cancer Statistics 2023 report.
Approximately 30‑50 % of cancers are preventable through lifestyle changes. Key measures include:
Screening programs (e.g., mammography, colonoscopy) catch many cancers at early, more treatable stages.
Therapies are selected based on cancer type, stage, and patient health. Main modalities include:
Removes localized tumors and can be curative for early‑stage disease.
Uses cytotoxic drugs to kill rapidly dividing cells; often combined with other treatments.
Delivers high‑energy beams to damage DNA in cancer cells while sparing surrounding tissue.
Blocks specific molecular pathways (e.g., HER2 inhibitors for HER2‑positive breast cancer).
Activates the immune system; checkpoint inhibitors like pembrolizumab have shown durable responses in melanoma and lung cancer.
Clinical trials continue to expand the arsenal, with personalized medicine based on genomic profiling becoming increasingly common.
In 2023, cancer accounted for 19.3 million new cases and 10 million deaths worldwide, making it the second leading cause of death after cardiovascular disease. The economic burden is estimated at US $1.5 trillion annually, including direct medical costs and lost productivity.
Key areas of innovation include:
These advances aim to shift care from reactive treatment toward proactive prevention and precision therapy.
Early signs vary by organ, but several warning signals are shared across many types:
Any of these symptoms lasting more than a few weeks should prompt a medical evaluation.
Genomic profiling identifies mutations that drive tumor growth, allowing clinicians to match patients with targeted drugs. For example, patients with non‑small cell lung cancer that harbor an EGFR exon 19 deletion respond well to EGFR inhibitors such as erlotinib.
| Biomarker | Associated cancer | Targeted therapy |
|---|---|---|
| HER2 amplification | Breast, gastric | Trastuzumab |
| BRCA1/2 mutation | Breast, ovarian | PARP inhibitors (olaparib) |
| PD‑L1 expression | Lung, melanoma | Pembrolizumab |
| KRAS G12C | Colorectal, lung | Sotorasib |
Patients whose tumors lack actionable mutations may still benefit from immunotherapy based on tumor mutational burden or microsatellite instability status.
Dietary patterns influence both the likelihood of developing cancer and the body’s ability to tolerate treatment. A 2022 meta‑analysis of 95 cohort studies found that a high intake of fruits, vegetables, and whole grains reduced overall cancer risk by 15 % compared with a diet low in plant foods.
During chemotherapy or radiation, adequate protein (1.2–1.5 g/kg body weight per day) helps preserve muscle mass, while omega‑3 fatty acids may lessen inflammation and improve appetite.
Conversely, excessive consumption of processed red meat and sugary beverages is linked to higher rates of colorectal and pancreatic cancers.
Trusted sources include national health agencies such as the U.S. National Cancer Institute (NCI) and the World Health Organization (WHO), as well as peer‑reviewed journals like The Lancet Oncology. Cancer support organizations (e.g., American Cancer Society) provide up‑to‑date guidelines on screening, survivorship, and clinical trials.
Global five‑year survival has risen from 44 % in 1990 to 67 % in 2023, driven by earlier detection, minimally invasive surgery, and novel systemic therapies. The WHO’s 2030 Cancer Control Plan aims to reduce premature mortality by 25 % through expanded screening and equitable access to treatment.
Screening intervals depend on age, sex, and risk factors. For example, mammograms are recommended every two years for women aged 50‑74, colonoscopy every ten years starting at age 45, and low‑dose CT for high‑risk smokers annually. Discuss personal risk with a healthcare provider to tailor a schedule.
Chemotherapy can cause fatigue, nausea, hair loss, increased infection risk due to low white‑blood‑cell counts, and peripheral neuropathy. Side effects vary by drug and dose; many can be managed with anti‑emetics, growth‑factor support, and dose adjustments. Long‑term monitoring is important for heart or organ toxicity.
Metastatic cancer is rarely curable, but modern therapies can achieve long‑term remission for some patients. Targeted agents, immunotherapies, and combination regimens can control disease for years, turning it into a chronic condition. Treatment goals focus on extending survival and maintaining quality of life.
Yes. Quitting smoking, maintaining a healthy weight, exercising regularly, limiting alcohol, and eating a plant‑rich diet can reduce the risk of many cancers by 15‑30 %. Vaccinations against HPV and hepatitis B also prevent virus‑related cancers. These changes complement medical screening.
Key takeaways:Baththa is a Tamil action-comedy streaming on Netflix, starring Vijay Sethupathi and Lijomol Jose,…
Key takeaways:Six occupants died in the crash near Joshimath, Uttarakhand.The flight was en route from…
Key takeaways:Le Havre vs PSG is a Ligue 1 match tonight with a 6pm kickoff…
Key takeaways:Konyaspor vs Galatasaray is a Turkish Süper Lig fixture with a BBC stats and…
Key takeaways:Tihar Jail has recorded prisoner escapes since 1965, and Delhi's prisons are actively working…
Key takeaways:Nasdaq faces a $2 trillion wipeout in October as AI spending fears deepen.Amazon and…